Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron PharmafiledCriticalAgouron Pharma
Priority to UY27331ApriorityCriticalpatent/UY27331A1/en
Publication of UY27331A1publicationCriticalpatent/UY27331A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
Compuestos de fórmula: donde las variables de la fórmula que se definió en el presente inhiben o bloquean favorablemente la actividad biológica de la proteasa de VIH. Estos compuestos, así como las composiciones farmacéuticas que los contienen, son útiles para el tratamiento de pacientes o portadores infectados con el virus VIH. También se describen productos intermedios y métodos sintéticos para la preparación de dichos compuestos.Formula compounds: where the variables of the formula defined herein inhibit or favorably block the biological activity of the HIV protease. These compounds, as well as the pharmaceutical compositions containing them, are useful for the treatment of patients or carriers infected with the HIV virus. Intermediates and synthetic methods for the preparation of said compounds are also described.
UY27331A2002-06-112002-06-11
HIV PROTEASE INHIBITORS, COMPOSITIONS THAT CONTAIN THEM, THEIR PHARMACEUTICAL AND MATERIAL USES FOR SYNTHESIS
UY27331A1
(en)
HYDROTIENOPYRIDINE 3-CYANE N-SUBSTITUTE COMPOUNDS USEFUL TO PREVENT AND TREAT VIRAL INFECTIONS, ESPECIALLY DENGUE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM